Pharmacotherapeutic group: cold and cough preparations; expectorants, excluding combinations with antitussives, ATC code: R05CA10
Mechanism of action:
The mechanism of action has not yet been identified.
Clinical efficacy and safety:
A randomised, placebo-controlled clinical study demonstrated the efficacy of 10-day treatment with a herbal medicinal product of essentially the same composition as Bronchipret thyme and ivy in adult patients with acute bronchitis with productive cough. Overall, treatment led to a faster and more comprehensive recovery from symptoms (cough bouts, Bronchitis Severity Score, etc.). A 50% reduction in cough bouts was, for example, achieved approximately 2 days earlier compared to placebo. Oral treatment was safe and well tolerated.
The safety and efficacy of Bronchipret thyme and ivy is supported by data from non-interventional studies.
⚠️ Warnings
If symptoms persist for more than 7 days or worsen during use, a doctor should be consulted.
If dyspnoea, fever, or purulent or bloody sputum occurs, a doctor should be consulted.
Caution is recommended in patients with gastritis or gastric ulcer. Patients with gastritis or gastric ulcer should consult a doctor before using Bronchipret thyme and ivy.
This medicinal product contains maltitol solution.
This medicinal product contains 34.20 mg of sorbitol per 1.85 ml of solution, corresponding to 18.5 mg/ml. Patients with rare hereditary problems of fructose intolerance should not take this medicinal product.
This medicinal product contains approximately 310 mg of alcohol (ethanol) per 1.85 ml of solution, corresponding to 168 mg/ml (15% w/w). The amount in 1.85 ml of this product is equivalent to less than 8 ml of beer or 4 ml of wine. The small amount of alcohol in this medicinal product has no noticeable effects.
PillsCard reference image